查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
臨床試驗管理服務市場:規模，佔有率，趨勢分析報告:各類服務，各業界，各適應症，各地區，各市場區隔預測(2022年～2030年)
市場調查報告書
商品編碼
1171130

臨床試驗管理服務市場:規模，佔有率，趨勢分析報告:各類服務，各業界，各適應症，各地區，各市場區隔預測(2022年～2030年)

Clinical Trial Management Services Market Size, Share & Trends Analysis Report By Services (Clinical Trial Monitoring, Regulatory Submissions), By Industry, By Indication, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 275 Pages | 商品交期: 2-10個工作天內

價格

全球臨床試驗管理服務的市場規模在2022年～2030年的預測期間內預計將以7.5％的年複合成長率擴大，到2030年前將達到521億美元。

臨床試驗活動的外包傾向提升，先進性治療方法研究開發的增加，臨床試驗的世界化等，是推動市場成長的主要原因。

本報告提供全球臨床試驗管理服務市場相關調查，提供市場現狀，以及各類服務，各業界，各適應症，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 調查手法和範圍

第2章 摘要整理

第3章 臨床試驗管理服務市場變數，趨勢，範圍

  • 市場系列預測
  • 滲透與成長預測的製圖
  • 市場動態
    • 推動市場要素分析
    • 阻礙市場要素分析
    • 滲透與成長預測的製圖
    • COVID-19影響與復甦的分析
    • 主要交易和策略性聯盟分析
    • 產業分析- 波特的五力分析
    • 大環境分析

第4章 臨床試驗管理服務市場:各類服務市場區隔分析

  • 臨床試驗管理服務市場:定義和範圍
  • 臨床試驗管理服務市場:各類服務市場佔有率分析，2021年及2030年
    • 臨床試驗監測
    • 法規當局的繳交
    • 臨床試驗資料管理
    • 醫學寫作
    • 網站管理和監視
    • 其他

第5章 臨床試驗管理服務市場:各業界市場區隔分析

  • 臨床試驗管理服務市場:定義和範圍
  • 臨床試驗管理服務市場:各業界市場佔有率分析，2021年及2030年
    • 醫藥品
    • 生物醫藥品
    • 醫療設備

第6章 臨床試驗管理服務市場:各適應症各市場區隔分析

  • 臨床試驗管理服務市場:定義和範圍
  • 臨床試驗管理服務市場:各適應症市場佔有率分析，2021年及2030年
    • 免疫學
    • 血液學
    • 腫瘤學
    • 神經學
    • 皮膚科
    • 其他

第7章 臨床試驗管理服務市場:各地區分析

  • 臨床試驗管理服務:各地區市場佔有率分析，2021年及2030年
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第8章 競爭情形

  • 臨床試驗管理服務市場:企業的市場佔有率分析，2021年及2030年
  • 企業簡介
    • SGS
    • LabCorp
    • IQVIA, Inc.
    • Syneous Health
    • Atlantic Research Group
    • ICON PLC
    • Clinical Trial &Consulting Services
    • Charles River Laboratories
    • Med pace
    • Wuxi Apptec
Product Code: GVR-4-68039-993-8

Clinical Trial Management Services Market Growth & Trends:

The global clinical trial management services market size is anticipated to reach USD 52.1 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.5% from 2022 to 2030. The increasing trend of outsourcing clinical trial activities, the rise in research and development of advanced therapies, and the globalization of clinical trials are a few key factors driving the growth of the market.

The number of clinical trials has significantly increased in the past two decades. This is due to the rising need for novel pharmaceutical products with improved efficacy as well as the increasing penetration of cutting-edge medical technologies. According to Clinical trials.gov, the total number of clinical trials accounted for 325,773 in 2020, whereas, as of April 2022, the number of clinical trials this year totaled more than 410,903.

Clinical trial management services such as clinical monitoring, data management, site monitoring, and medical writing service are cost-effective and time-saving. These also harmonize clinical data across sites and failure rates. Furthermore, the integration of digital technologies, including cloud computing, Artificial Intelligence (AI), big data prescriptive, and predictive analytics, the Internet of Medical Things, and mobile technology remain major developments on the horizon. These technologies have shown great promise in improving productivity while accelerating the pace of clinical trials.

The COVID-19 pandemic significantly impacted the market. It created an unexpected urgency for alternative solutions to clinical trial execution, limiting on-site monitoring visits. It prompted researchers to use remote clinical trial monitoring services and platforms to reduce the spread of the COVID-19 infection as well as to simultaneously function in clinical research. For instance, according to the Florence survey in 2020, more than 60% of clinical study sites and clinical trial sponsors stated more than 50% acceptance of remote site monitoring solutions for clinical research.

Clinical Trial Management Services Market Report Highlights:

  • The clinical trial monitoring segment dominated the market with a revenue share of 31.6% in 2021. Technological advancement in trial monitoring is one of the key factors driving the growth of the market.
  • The oncology segment is anticipated to hold the highest market share of 31.0% in 2021 in the clinical trial management services market. High shares of the segment are majorly due to the increasing cases of cancer across the globe.
  • Based on industry, pharmaceuticals accounted for the largest market share of 38.9% in 2021. The companies have adopted technologies such as cloud computing and AI to improve patient engagement and reduce trial failures to drive market growth.
  • Asia Pacific is projected to witness the fastest CAGR-driven growth of 8.5% during the forecast period. Factors such as the cheap labor cost, a diverse patient pool, lowered costs of clinical trial activities

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Services
    • 1.1.2. Industry
    • 1.1.3. Indication
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Volume price analysis (Model 2)
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2
    • 1.9.3. Objective 3
    • 1.9.4. Objective 4

Chapter 2. Executive Summary

  • 2.1. Market Outlook

Chapter 3. Clinical Trial Management Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Increasing technological advancement in the clinical trial monitoring services
      • 3.3.1.2. Rise in R&D expenditure by pharmaceutical and biopharmaceutical companies
      • 3.3.1.3. Growth in the number of outsourced projects related to clinical trial management services
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. High cost associated with clinical trial management services
      • 3.3.2.2. Stringent regulatory policies for clinical trial management services
    • 3.3.3. Penetration & Growth Prospect Mapping
    • 3.3.4. Covid-19 Impact & Recovery Analysis
    • 3.3.5. Major Deals and Strategic Alliances Analysis
    • 3.3.6. Industry Analysis - Porter's Five Forces
    • 3.3.7. PESTLE Analysis

Chapter 4. Clinical Trial Management Services Market: Services Segment Analysis

  • 4.1. Clinical Trial Management Services Market: Definition & Scope
  • 4.2. Clinical Trial Management Services Market: Services Market Share Analysis, 2021 & 2030
    • 4.2.1. Clinical Trial Monitoring
      • 4.2.1.1. Clinical Trial Monitoring Market, 2018 - 2030 (USD Million)
    • 4.2.2. Regulatory Submissions
      • 4.2.2.1. Regulatory Submissions Market, 2018 - 2030 (USD Million)
    • 4.2.3. Clinical Trial Data Management
      • 4.2.3.1. Clinical Trial Data Management Market, 2018 - 2030 (USD Million)
    • 4.2.4. Medical Writing
      • 4.2.4.1. Medical Writing Market, 2018 - 2030 (USD Million)
    • 4.2.5. Site management & monitoring
      • 4.2.5.1. Site management & monitoring Market, 2018 - 2030 (USD Million)
    • 4.2.6. Others
      • 4.2.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Clinical Trial Management Services Market: Industry Segment Analysis

  • 5.1. Clinical Trial Management Services Market: Definition & Scope
  • 5.2. Clinical Trial Management Services Market: Industry Market Share Analysis, 2021 & 2030
    • 5.2.1. Pharmaceuticals
      • 5.2.1.1. Pharmaceuticals Market, 2018 - 2030 (USD Million)
    • 5.2.2. Biopharmaceuticals
      • 5.2.2.1. Biopharmaceuticals Market, 2018 - 2030 (USD Million)
    • 5.2.3. Medical Devices
      • 5.2.3.1. Medical Devices Market, 2018 - 2030 (USD Million)

Chapter 6. Clinical Trial Management Services Market: Indication Segment Analysis

  • 6.1. Clinical Trial Management Services Market: Definition & Scope
  • 6.2. Clinical Trial Management Services Market: Indication Market Share Analysis, 2021 & 2030
    • 6.2.1. Immunology
      • 6.2.1.1. Immunology Market, 2018 - 2030 (USD Million)
    • 6.2.2. Hematology
      • 6.2.2.1. Hematology Market, 2018 - 2030 (USD Million)
    • 6.2.3. Oncology
      • 6.2.3.1. Oncology Market, 2018 - 2030 (USD Million)
    • 6.2.4. Neurology
      • 6.2.4.1. Neurology Market, 2018 - 2030 (USD Million)
    • 6.2.5. Dermatology
      • 6.2.5.1. Oncology Market, 2018 - 2030 (USD Million)
    • 6.2.6. Others
      • 6.2.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Clinical Trial Management Services Market: Regional Analysis

  • 7.1. Clinical Trial Management Services: Regional market share analysis, 2021 & 2030
  • 7.2. North America
    • 7.2.1. U.S. Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.4. Italy
      • 7.3.4.1. Italy Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.3.6. France
      • 7.3.6.1. France Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.3. India
      • 7.4.3.1. India Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.4. Japan
      • 7.4.4.1. Japan Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Mexico Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.5.4. Argentina
      • 7.5.4.1. Argentina Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. MEA Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Arabia
      • 7.6.3.1. South Africa Clinical Trial Management Services Market, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE Clinical Trial Management Services Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Clinical Trial Management Services: Company market share analysis, 2021 & 2030
  • 8.2. Company Profiles
    • 8.2.1. SGS
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Service benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. LabCorp
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Service benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. IQVIA, Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Service benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Syneous Health
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Service benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Atlantic Research Group
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Service benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. ICON PLC
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Service benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Clinical Trial & Consulting Services
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Service benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Charles River Laboratories
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Service benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Med pace
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Service benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Wuxi Apptec
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Service benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary sources
  • Table 2 List of Abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Volume price analysis
  • Fig. 9 Clinical trial management services market snapshot (2021)
  • Fig. 10 Clinical trial management services market segmentation
  • Fig. 11 Heat map analysis
  • Fig. 12 Parent market outlook
  • Fig. 13 Ancillary market outlook
  • Fig. 14 Penetration & growth prospect mapping
  • Fig. 15 Market driver relevance analysis (Current & future impact)
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 19 Clinical trial management services market services outlook: Segment dashboard
  • Fig. 20 Clinical trial management services market: Services movement analysis
  • Fig. 21 Clinical trial monitoring market, 2018 - 2030 (USD Million)
  • Fig. 22 Regulatory submissions market, 2018 - 2030 (USD Million)
  • Fig. 23 Clinical trial data management market, 2018 - 2030 (USD Million)
  • Fig. 24 Medical writing market, 2018 - 2030 (USD Million)
  • Fig. 25 Site management & monitoring market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Clinical trial management services market industry outlook: Segment dashboard
  • Fig. 28 Clinical trial management services market: Industry movement analysis
  • Fig. 29 Pharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 30 Biopharmaceuticals market, 2018 - 2030 (USD Million)
  • Fig. 31 Medical devices market, 2018 - 2030 (USD Million)
  • Fig. 32 Clinical trial management services market indication outlook: Segment dashboard
  • Fig. 33 Clinical trial management services market: Indication movement analysis
  • Fig. 34 Immunology testing market, 2018 - 2030 (USD Million)
  • Fig. 35 Hematology market, 2018 - 2030 (USD Million)
  • Fig. 36 Oncology market, 2018 - 2030 (USD Million)
  • Fig. 37 Neurology market, 2018 - 2030 (USD Million)
  • Fig. 38 Other tests market, 2018 - 2030 (USD Million)
  • Fig. 39 Regional market: Key takeaways
  • Fig. 40 Clinical trial management services market: Regional movement analysis
  • Fig. 41 North America. market, 2018 - 2030 (USD Million)
  • Fig. 42 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 43 Canada market, 2018 - 2030 (USD Million)
  • Fig. 44 Europe market, 2018 - 2030 (USD Million)
  • Fig. 45 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany market, 2018 - 2030 (USD Million)
  • Fig. 47 France market, 2018 - 2030 (USD Million)
  • Fig. 48 Italy market, 2018 - 2030 (USD Million)
  • Fig. 49 Spain market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market, 2018 - 2030 (USD Million)
  • Fig. 52 China market, 2018 - 2030 (USD Million)
  • Fig. 53 India market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 59 MEA market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE market, 2018 - 2030 (USD Million)